REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,247 | +3.5% | 3,152 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $84,316 | +175558.3% | 3,152 | +42.6% | 0.00% | – |
| Q1 2023 | $48 | -9.4% | 2,210 | 0.0% | 0.00% | – |
| Q4 2022 | $53 | -99.9% | 2,210 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +7.1% | 2,210 | +2.8% | 0.00% | – |
| Q2 2022 | $42,000 | +16.7% | 2,150 | +53.6% | 0.00% | – |
| Q1 2022 | $36,000 | -29.4% | 1,400 | -41.2% | 0.00% | – |
| Q4 2021 | $51,000 | -25.0% | 2,380 | -3.6% | 0.00% | – |
| Q3 2021 | $68,000 | -12.8% | 2,470 | 0.0% | 0.00% | – |
| Q2 2021 | $78,000 | +13.0% | 2,470 | +64.7% | 0.00% | – |
| Q1 2021 | $69,000 | +16.9% | 1,500 | 0.0% | 0.00% | – |
| Q4 2020 | $59,000 | -7.8% | 1,500 | -18.0% | 0.00% | -100.0% |
| Q3 2020 | $64,000 | – | 1,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |